
International Symposium on Technical Innovations in Laboratory Hematology
Date: April 17 - 19, 2026
Location: Edinburgh, Scotland
Venue: Edinburgh International Convention Centre (maps)
When Hematology and Hemostasis come together, laboratories operate more efficiently. These disciplines are naturally connected and unifying them into a single hematology and hemostasis workflow helps labs shift from siloed testing to a truly connected blood science strategy. The outcome is a more streamlined journey. Hematology and hemostasis testing can be highly hands-on, with time-intensive steps such as sample preparation, result interpretation, troubleshooting, and manual review—particularly for complex cases. Laboratories need solutions that reduce manual interventions, especially where specialized expertise is required.
Siemens Healthineers offers specialized solutions designed to reduce manual effort, enhance footprint, and simplify sample handling. Fully integrated and automated hematology and hemostasis solutions help ease the workload on laboratory staff, enabling them to spend more time on higher-value activities.
Unlock the power of a comprehensive suite of integrated blood testing solutions, featuring advanced optical methods, routine platelet aggregation testing, and AI-driven full-field imaging. See how our portfolio helps you tackle staffing challenges and enhance efficiency across your entire testing workflow.

The Atellica HEMA 580 Analyzer is designed to meet the hematology testing needs of today’s high-volume labs. With fast throughput, the instrument is intended to pair with advanced informatics and automation solutions to suit diverse workflow requirements and drive efficiencies across labs and networks.

Experience the power of Scopio X100 and X100HT—the first full-field digital cell morphology platforms with AI-driven decision support to enhance accuracy and efficiency. These cutting-edge systems automate slide scanning, helping eliminate manual reviews and saving valuable time in your lab.

See how the CN-3000 and CN-6000 Hemostasis Systems are transforming coagulation testing with fast, smart, and flexible solutions—all in a compact design. Learn how features like automated barcode scanning and cap piercing can help your lab reduce manual steps and improve efficiency.
Explore our scalable and customizable portfolio of automated lab and IT solutions designed to streamline workflows in labs of all sizes. See how our technologies help accelerate access to critical information while freeing up time from routine tasks.
Many conditions involve both hematological and hemostatic factors, making integrated testing key to faster, more efficient diagnoses. Collaboration across disciplines helps uncover clearer insights—especially in complex cases like coagulopathies or thrombocytopenia. See how Atellica Diagnostics IT brings it all together by consolidating data from multiple sources, reducing manual entry, and delivering a complete clinical picture.
Our adaptable portfolio of automated laboratory solutions is built to support a wide range of testing volumes, space constraints, and specialty needs. Designed for laboratories of all sizes, these flexible and innovative options help drive standardization and improve workflow efficiency through automation.

Reduce time and effort spent on low-value tasks and complex workstreams by connecting the Atellica HEMA 580 Analyzer to lab automation. Automation connectivity helps improve resource utilization, increase efficiency, and achieve consistent turnaround times.

Could lab automation from Siemens Healthineers be the solution for your lab? Automate hemostasis and hematology in a compact workcell, with single-tube transport, centrifugation, and automatic aliquoting to reduce manual steps, expand your test menu, and free up time—all in a small footprint. Learn about the wins.

Unlock holistic insights into blood science with versatile automation—whether for single- or multidisciplinary testing. From clinical chemistry and immunoassay to hemostasis, hematology, plasma proteins, and allergy testing, streamline it all with one trusted partner and simplify your lab’s vendor management.

Our lab automation solutions let you flexibly add analyzers and workflow modules, like pre- and post-analytics, to fit your space and needs. Together with our healthcare consulting specialists, tailor a configuration that meets your clinical and operational needs and helps you achieve more with less.
Designed to address a wide range of hemostasis testing needs, our solutions help laboratories generate reliable results, improve workflow efficiency, and support informed clinical decision making.
Hemostasis disorders require precise testing across multiple disease states. Our comprehensive assay portfolio supports both routine and specialty assays, enabling laboratories to evaluate bleeding and thrombotic conditions while supporting a more holistic approach to disease management.
Supporting laboratories in the evaluation of clotting disorders, thrombophilia, anticoagulation therapy, platelet dysfunctions, and more as we continue to expand testing possibilities.

Our coming portfolio addition, designed to exclude DVT /PE and help assess DIC with speed, efficiency and confidence. Comes with liquid, ready to use reagents and controls.
Ask our booth staff!

Now FDA-cleared in the U.S. as a companion diagnostic for QFITLIA (fitusiran). The liquid assay delivers consistent results across systems—supporting harmonized interpretation and reducing repeat testing to save time and reagents.

Discover how the INNOVANCE Anti-Xa assay brings advanced, automated testing to your lab with fast, accurate measurement of UFH, LMWH, and direct oral anticoagulants like rivaroxaban, apixaban, and edoxaban.1 With minimal hands-on time, this chromogenic assay helps reduce human error and streamline your workflow.

A breakthrough in making aggregation testing easier, more reliable, and standardized—automating platelet aggregation for five agonists with no extra pipetting or hands-on steps required.
Join our symposium to explore CBC flags and how they play a critical role in modern hematology, serving as early signals that guide laboratory review and prioritization. But are these flags the starting point of a broader diagnostic journey—or too often treated as the final stop?
In this Hematology MythBusters panel, leading experts from clinical hematology, laboratory medicine, and industry innovators examine how laboratories can move beyond CBC flags to fully leverage digital morphology, automation, and integrated data pathways. Through a combination of short expert presentations and an interactive “Myth or Fact?” discussion, panelists will explore how early detection, standardized workflows, and connected systems work together to support consistent interpretation and contextual understanding of hematologic findings.
We are proud to participate in this year's poster session with our customers, showcasing scientific findings from key research. Come visit us and see this year’s posters. Below is a preview of each one:
Comparison of blood film review rates between Atellica HEMA and ADVIA 2120i hematology analyzers
Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
Atellica HEMA 570 and Atellica HEMA 580 analyzers were recently launched by Siemens Healthcare Diagnostics Inc. to replace their legacy ADVIA 2120i Hematology Systems. Low blood film review rates are a welcome and, increasingly, an expected feature of hematology analyzers in modern high-throughput laboratories. The purpose of this study was to compare blood film review rates between the new Atellica HEMA and our legacy ADVIA 2120i automated hematology analyzers.
Preliminary analytical performance data of a new D-dimer assay
Siemens Healthcare Diagnostics Products GmbH, Marburg, Germany
D-dimer is a global indicator of coagulation activation and fibrinolysis and an indirect marker of thrombotic activity. The major diagnostic application of D-dimer testing lies in the exclusion of thromboembolic events, such as deep vein thrombosis (DVT) or pulmonary embolism (PE) and has been implemented into corresponding guidelines. The INNOVANCE D-Dimer 2.0 assay3 for the quantitative, non-standardized determination of D-dimer was investigated for its key analytical performance characteristics on a variety of coagulation analyzers.
We look forward to seeing you at ISLH.